Skip to content

A Clinical Study of Precision-Targeted Transcranial Magnetic Stimulation(TMS) Based on Personalized Brain Models and Robotic Arm Navigation for Subjective Tinnitus

A Clinical Study of Precision-Targeted Transcranial Magnetic Stimulation(TMS) Based on Personalized Brain Models and Robotic Arm Navigation for Subjective Tinnitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128193
Enrollment
Unknown
Registered
2026-07-15
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Interventions

Standard Treatment Control Group:Standard repetitive transcranial magnetic stimulation
Sham / Placebo Control Group:Placebo sham stimulation
Precision-Targeted rTMS Group:Personalized brain model-guided robotic arm navigated precision-targeted repetitive transcranial magnetic stimulation

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years and = 6 months; 3. Right-handed; 4. Capable of independently completing all scale assessments; 5. Previously unresponsive to drug treatment, and voluntarily participating in the study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Objective tinnitus (vascular, myogenic, or other types audible to others), or tinnitus caused by an identifiable active etiology, such as: acute otitis media, acute phase of Ménière's disease, acoustic neuroma, active temporomandibular joint disorder, etc.; 2.Contraindications to rTMS: including metal foreign bodies in the skull, cardiac pacemaker, wires or metal stents in the heart, traumatic brain injury, increased intracranial pressure, abnormal brain signs or intracranial tumors, cerebrovascular disease, neurodegenerative diseases of the cranial nerves, non-removable metal objects in or around the body, history of epilepsy or family history of epilepsy, history of electroconvulsive therapy, pregnancy; 3.Communication disorders or inability to cooperate; 4.Contraindications to MRI (e.g., presence of ferromagnetic aneurysm clips, pacemakers); 5.Use of sedatives or GABA-acting medications within the past month.

Design outcomes

Primary

MeasureTime frame
Clinical response rate;

Secondary

MeasureTime frame
HAMD score;Beck Depression Inventory (BDI);HADS score;

Countries

China

Contacts

Public ContactDuoduo Tao

The First Affiliated Hospital of Soochow University

entdtao@163.com+86 512 67975520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026